DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Multaq (Dronedarone) - Published Studies

 
 



Multaq Related Published Studies

Well-designed clinical trials related to Multaq (Dronedarone)

Estimation of potential cost savings associated with reduced rates of cardiovascular hospitalization among atrial fibrillation/flutter patients treated with dronedarone in the ATHENA trial. [2014]

Effects of dronedarone started rapidly after amiodarone discontinuation. [2013]

Rhythm- and rate-controlling effects of dronedarone in patients with atrial fibrillation (from the ATHENA trial). [2011.04.01]

Impact of dronedarone on hospitalization burden in patients with atrial fibrillation: results from the ATHENA study. [2011]

Effect of dronedarone on exercise capacity and cardiac function in patients with severe left ventricular dysfunction and compensated stable heart failure. [2010.12]

Dronedarone therapy in atrial fibrillation: a summary of recent controlled trials. [2010.12]

Dronedarone Therapy in Atrial Fibrillation: A Summary of Recent Controlled Trials. [2010.05.14]

Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter. [2009.09.29]

Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation. [2009.09.15]

Effect of dronedarone on cardiovascular events in atrial fibrillation. [2009.02.12]

Dronedarone for the control of ventricular rate in permanent atrial fibrillation: the Efficacy and safety of dRonedArone for the cOntrol of ventricular rate during atrial fibrillation (ERATO) study. [2008.09]

Increased mortality after dronedarone therapy for severe heart failure. [2008.06.19]

Rationale and design of ATHENA: A placebo-controlled, double-blind, parallel arm Trial to assess the efficacy of dronedarone 400 mg bid for the prevention of cardiovascular Hospitalization or death from any cause in patiENts with Atrial fibrillation/atrial flutter. [2008.01]

Effect of dronedarone on renal function in healthy subjects. [2007.12]

Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter. [2007.09.06]

Well-designed clinical trials possibly related to Multaq (Dronedarone)

New approaches to atrial fibrillation management: treat the patient, not the ECG. [2010.10]

New Approaches to Atrial Fibrillation Management: Treat the Patient, not the ECG. [2010.03.25]

Other research related to Multaq (Dronedarone)

The role of dronedarone in the treatment of atrial fibrillation/flutter in the aftermath of PALLAS. [2014]

Dronedarone for the Treatment of Atrial Fibrillation: A NICE Single Technology Appraisal. [2011.12.02]

Dronedarone and the Incidence of Stroke in Patients with Paroxysmal or Persistent Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Trials. [2011.10.31]

Impact of dronedarone on hospitalization burden in patients with atrial fibrillation: results from the ATHENA study. [2011.08]

Dronedarone for atrial fibrillation therapy. [2011.06]

Effect of dronedarone on Na+, Ca2+ and HCN channels. [2011.04]

Dronedarone for the management of atrial fibrillation. [2011.03.02]

[Perspectives and recommendations for the anti-arrhythmic treatment of atrial fibrillation: focus on dronedarone]. [2011.03]

Dronedarone for atrial fibrillation: How does it compare with amiodarone? [2011.03]

Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation. [2011.03]

Dronedarone. [2011.02]

Dronedarone: current evidence for its safety and efficacy in the management of atrial fibrillation. [2011.01.06]

[The role of dronedarone in the contemporary atrial fibrillation treatment]. [2011.01]

Dronedarone as a new treatment option for atrial fibrillation patients: pharmacokinetics, pharmacodynamics and clinical practice. [2011.01]

Effects of dronedarone on clinical outcomes in patients with lone atrial fibrillation: pooled post hoc analysis from the ATHENA/EURIDIS/ADONIS studies. [2011]

Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation. [2011]

A review of the appropriate and inappropriate use of dronedarone: lessons learned from controlled studies and regulatory submission. [2010.12]

[Dronedarone]. [2010.12]

Synergistic effect of the combination of ranolazine and dronedarone to suppress atrial fibrillation. [2010.10.05]

Dronedarone for the treatment of atrial fibrillation and atrial flutter. [2010.10]

Dronedarone and vitamin K antagonists: a review of drug-drug interactions. [2010.10]

Dronedarone: a new antiarrhythmic agent. [2010.09]

Worsening heart failure in the setting of dronedarone initiation. [2010.09]

Effect of Dronedarone on Exercise Capacity and Cardiac Function in Patients With Severe Left Ventricular Dysfunction and Compensated Stable Heart Failure. [2010.07.21]

Dronedarone in patients with congestive heart failure: insights from ATHENA. [2010.07]

A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study. [2010.06.01]

Dronedarone: a review of characteristics and clinical data. [2010.06]

Dronedarone: an emerging therapy for atrial fibrillation. [2010.06]

Dronedarone for atrial fibrillation have we expanded the antiarrhythmic armamentarium? [2010.04.13]

Impact of dronedarone in atrial fibrillation and flutter on stroke reduction. [2010.04.07]

[Preventing stroke by treating atrial fibrillation--new hope with dronedarone and dabigatran?] [2010.03]

[Clinical pharmacology and electrophysiological properties of dronedarone] [2010.03]

[Clinical profile of the new antiarrhythmic drug dronedarone] [2010.03]

Dronedarone: current evidence and future questions. [2010.03]

Dronedarone--a new alternative for management of atrial fibrillation. [2010.01.01]

Efficacy and safety of dronedarone: a review of randomized trials. [2010.01]

Dronedarone: a novel antiarrhythmic agent for the treatment of atrial fibrillation. [2010.01]

Dronedarone for the treatment of atrial fibrillation and atrial flutter. [2010]

Dronedarone in patients with congestive heart failure: insights from ATHENA. [2010]

Dronedarone: a novel antiarrhythmic agent for the treatment of atrial fibrillation. [2010]

Dronedarone: a promising alternative for the management of atrial fibrillation. [2009.10]

Dronedarone: a new antiarrhythmic agent for the treatment of atrial fibrillation. [2009.09]

Estradiol valerate/dienogest: in oral contraception. [2009.08.20]

Dronedarone. [2009.08.18]

[Dronedarone: the new antiarrythmic agent?] [2009.06]

Antiarrhythmic drugs for atrial fibrillation: focus on dronedarone. [2009.05]

Dronedarone for atrial fibrillation: a new therapeutic agent. [2009]

Other possibly related research studies

Prevention of stroke in patients with atrial fibrillation: the role of new antiarrhythmic and antithrombotic drugs. [2010.08]

Cost burden of cardiovascular hospitalization and mortality in ATHENA-like patients with atrial fibrillation/atrial flutter in the United States. [2010.05]

Antiarrhythmic and nonantiarrhythmic drugs for sudden cardiac death prevention. [2010.05]

New and emerging antiarrhythmic and anticoagulant agents for atrial fibrillation. [2010.05.01]

New antiarrhythmic drugs for treatment of atrial fibrillation. [2010.04.03]

[Current antiarrhythmic drug therapy in atrial fibrillation] [2010.03]

Recent advances in the pharmacological treatment of cardiac arrythmias. [2009.11]

Replacing aspirin and warfarin for secondary stroke prevention: is it worth the costs? [2010.02]

Amiodarone and thyroid. [2009.12]

Effects of amiodarone therapy on thyroid function. [2010.01]

Cardioversion of atrial fibrillation: the use of antiarrhythmic drugs. [2010.03]

New and emerging antiarrhythmic drugs for atrial fibrillation: what may become available to the clinician in the near future. [2009.10]

Atrial Ca2+ signaling in atrial fibrillation as an antiarrhythmic drug target. [2010.03]

Pharmacologic management of atrial fibrillation: established and emerging options. [2009.08]

[Treatment of atrial fibrillation in heart failure] [2009.03]

Novel approaches for pharmacological management of atrial fibrillation. [2009]

Major recent trials in cardiovascular diseases. [2009.03]

Pharmacotherapy for atrial arrhythmias: present and future. [2008.06]

Mixed learning algorithms and features ensemble in hepatotoxicity prediction. [2011.09]

Is antiarrhythmic treatment in the elderly different?: a review of the specific changes. [2011.08.01]

Atrial fibrillation: epidemiology, prognosis and therapy. [2011.06]

Delayed and indirect effects of antiarrhythmic drugs in reducing sudden cardiac death. [2011.03]

[Treatment of atrial fibrillation: when to use drugs or to perform ablation]. [2010.10]

Antiarrhythmic drugs management in patients with atrial fibrillation: the new guidelines. [2011.04]

Treating arrhythmias: an expert opinion. [2011.06]

Post-ATHENA and beyond. [2011.06]

Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management. [2011.01]

Antiarrhythmic drugs for atrial fibrillation. [2011.06]

Electrophysiology and adult congenital heart disease: advances and options. [2011.01]

[Epidemiology, clinical picture and management of atrial fibrillation]. [2011.02]

Sinus rhythm restoration and treatment success: insight from recent clinical trials. [2011.01]

[Current management of atrial fibrillation: rhythm or rate control and thoughts about a new treatment paradigm]. [2010.12]

[Management of atrial fibrillation, what to know on old and new antiarrhythmics]. [2010.12]

The pharmaceutical pipeline for atrial fibrillation. [2011.02]

Advances in the treatment of atrial fibrillation. [2010.12]

Augmenting maintenance of sinus rhythm in the control of atrial fibrillation by antiarrhythmic drug combinations. [2010.12]

[New developments in the antiarrhythmic therapy of atrial fibrillation]. [2010.12]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017